WX20120108, a novel IAP antagonist, induces tumor cell autophagy via activating ROS-FOXO pathway.

MLA

Ding, Rui, et al. “WX20120108, a Novel IAP Antagonist, Induces Tumor Cell Autophagy via Activating ROS-FOXO Pathway.” Acta Pharmacologica Sinica, vol. 40, no. 11, Nov. 2019, pp. 1466–79. EBSCOhost, https://doi.org/10.1038/s41401-019-0253-5.

APA

Ding, R., Wang, X., Chen, W., Li, Z., Wei, A.-L., Wang, Q.-B., Nie, A.-H., & Wang, L.-L. (2019). WX20120108, a novel IAP antagonist, induces tumor cell autophagy via activating ROS-FOXO pathway. Acta Pharmacologica Sinica, 40(11), 1466–1479. https://doi.org/10.1038/s41401-019-0253-5

Chicago

Ding, Rui, Xin Wang, Wei Chen, Zhi Li, Ai-Li Wei, Qing-Bin Wang, Ai-Hua Nie, and Li-Li Wang. 2019. “WX20120108, a Novel IAP Antagonist, Induces Tumor Cell Autophagy via Activating ROS-FOXO Pathway.” Acta Pharmacologica Sinica 40 (11): 1466–79. doi:10.1038/s41401-019-0253-5.